Business Context and Reporting Period
This Form 8-K is a Current Report filed by Marathon Patent Group, Inc. (noting the metadata reference to MARA Holdings, Inc. appears to be a discrepancy as the filing explicitly names Marathon Patent Group, Inc.) on September 5, 2017, covering events occurring between August 30, 2017, and September 1, 2017. The company is an emerging growth company engaged in patent enforcement and licensing. The filing details significant restructuring activities, including the reduction of liabilities, modification of executive compensation, asset dispositions, and new debt financing.
Key Financial Metrics and Agreements
- Debt Financing: On August 31, 2017, the company issued 5% convertible promissory notes with an aggregate principal amount of $3,623,700, due May 31, 2018. Interest is payable in cash at maturity or upon conversion.
- Liability Reduction: Through a series of settlement agreements with creditors, outstanding payables were reduced from approximately $5,300,000 (as of June 30, 2017) to approximately $675,000.
- Asset Disposition: On September 1, 2017, the company sold its subsidiary Munitech IP S.a.r.l. to GPat Technologies, LLC for $25,000 cash, transferring all assets and assuming all liabilities of the subsidiary.
- Equity Issuance: In connection with the debt financing, the company issued warrants to purchase an aggregate of 18,118,500 shares of common stock at an exercise price of $0.30 per share.
- Projected Expenses: Following restructuring, projected monthly expenses are approximately $150,000 for September 2017 and $125,000 for October 2017 and subsequent months.
- Patent Portfolio: The company retains over 10,000 patents across various subsidiaries, with PG Technologies S.a.r.l. holding 10,000+ patents.
Material Changes Versus Prior Period
- Payables: A material reduction in outstanding payables occurred, decreasing by approximately $4.625 million from the June 30, 2017 balance.
- Executive Compensation: Significant changes were made to executive agreements:
- Doug Croxall (CEO): Retention agreement amended to eliminate COBRA reimbursement and reduce share awards to 2,800,000 shares with a monthly vesting schedule.
- Francis Knuettel II (CFO): Employment agreement terminated and replaced with a retention agreement providing a $15,000 monthly consulting fee for six months and 200,000 restricted shares.
- James Crawford (COO): Employment agreement revised to an at-will basis with monthly compensation of $7,500.
- Erich Spangenberg: Consulting agreement terminated and replaced with a new agreement for Page Innovations, LLC, providing 100,000 restricted shares for limited consulting hours.
- Capital Structure: The company incurred new debt obligations of $3.62 million and potential equity dilution through the issuance of warrants for 18.1 million shares.
Outlook, Risks, and Contingencies
- Outlook: Management indicates continued efforts to restructure liabilities and vendor agreements. The company is actively enforcing patent portfolios held by Clouding Corp. and CRFD Research, Inc.
- Risks and Contingencies:
- Dilution: The convertible notes and warrants are subject to beneficial ownership limitations (4.99% initially, up to 9.99% with notice), with a cumulative cap of 19.99% of outstanding shares until shareholder approval is obtained.
- Liquidity: The company relies on the recent debt financing and expense reductions to maintain operations. The filing notes ongoing negotiations with other creditors.
- Confidentiality: Specific payment terms for the Medtronic settlement agreement are confidential.
- Regulatory: The company must file pro forma financial statements within 71 days regarding the Munitech disposition.
Investor Verification Checklist
- Verify the exact terms of the $3,623,700 convertible notes, specifically the conversion price floor ($0.10) and ceiling ($0.20) and the impact on share count.
- Confirm the status of shareholder approval for the 2017 Equity Incentive Plan, which is a condition for issuing shares to executives and for the warrant/note conversion caps.
- Review the pro forma financial statements to be filed within 71 days to assess the financial impact of the Munitech sale.
- Monitor the progress of ongoing creditor negotiations to determine if the $675,000 payable balance is final or subject to further reduction.
- Validate the active enforcement status of the Clouding and CRFD patent portfolios as a primary revenue driver.